Print

Ignyta Appoints Jerry Hurst to Executive Advisory Board  
2/15/2013 9:14:57 AM

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc., the personalized medicine company dedicated to improving the diagnosis and treatment of patients with rheumatoid arthritis, lupus and other autoimmune diseases, announced today the appointment of Jerry Hurst, a veteran of CLIA lab operations and former manger of the state of California’s CLIA lab inspection program, to its Executive Advisory Board. “As Ignyta prepares to establish a leading CLIA lab to perform diagnostic services for autoimmune disease, we are assembling a team with proven track records in successful laboratory development, licensure and operations,” said Jonathan Lim, M.D., co-founder, chairman and CEO of Ignyta. “With over 30 years of experience in clinical laboratory science, including as manager of the state of California’s CLIA inspection program, and his subsequent involvement in the establishment of multiple commercial CLIA labs, Jerry has an unmatched understanding of what is required to successfully develop and operate a CLIA lab.”
//-->